Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T17:56:27.514Z.
Calculation as of: 2026-10-06T17:56:27.514Z.
Quote observation: 2026-10-06T17:55:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f97479f440d7a03605f533a56e26179237db48e588053495707f458dff3bcd44
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$5.06B
EV/Sales Ratio
3.44x
TTM Avg
3.38x
3Y Avg
3.94x
5Y Avg
3.84x
Market Cap
$5.06B
EV/Sales Ratio
N/A
TTM Avg
9.73x
3Y Avg
35.19x
5Y Avg
37.28x
Market Cap
$4.81B
EV/Sales Ratio
8.47x
TTM Avg
10.12x
3Y Avg
8.33x
5Y Avg
12.98x
Market Cap
$5.16B
EV/Sales Ratio
9.57x
TTM Avg
8.64x
3Y Avg
7.38x
5Y Avg
7.61x
Market Cap
$5.17B
EV/Sales Ratio
N/A
TTM Avg
205.59x
3Y Avg
62.54x
5Y Avg
55.05x
Market Cap
$4.74B
EV/Sales Ratio
10.91x
TTM Avg
13.65x
3Y Avg
13.65x
5Y Avg
13.65x
Market Cap
$4.68B
EV/Sales Ratio
2402.38x
TTM Avg
1670.59x
3Y Avg
767.91x
5Y Avg
667.74x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $4.96B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 3.44x | 3.38x | 3.94x | 3.84x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | N/A | 9.73x | 35.19x | 37.28x |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.81B | 8.47x | 10.12x | 8.33x | 12.98x |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.80B | N/A | N/A | N/A | N/A |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.16B | 9.57x | 8.64x | 7.38x | 7.61x |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | N/A | 205.59x | 62.54x | 55.05x |
| BillionToOne, Inc. (BLLN)vs › | $4.74B | 10.91x | 13.65x | 13.65x | 13.65x |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.68B | 2402.38x | 1670.59x | 767.91x | 667.74x |
| Sotera Health Company (SHC)vs › | $5.24B | 5.88x | 5.80x | 5.60x | 6.14x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
